Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Lansbury, Peter
Item TypeName
Academic Article Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy.
Academic Article NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded.
Academic Article Amyloid fibril formation requires a chemically discriminating nucleation event: studies of an amyloidogenic sequence from the bacterial protein OsmB.
Academic Article Beta-synuclein inhibits formation of alpha-synuclein protofibrils: a possible therapeutic strategy against Parkinson's disease.
Academic Article Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils.
Academic Article Phosphorylation at Ser-129 but not the phosphomimics S129E/D inhibits the fibrillation of alpha-synuclein.
Academic Article Neurodegenerative disease: amyloid pores from pathogenic mutations.
Academic Article The N-terminal repeat domain of alpha-synuclein inhibits beta-sheet and amyloid fibril formation.
Academic Article An improved method of preparing the amyloid beta-protein for fibrillogenesis and neurotoxicity experiments.
Academic Article Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.
Academic Article Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid.
Academic Article The impact of the E46K mutation on the properties of alpha-synuclein in its monomeric and oligomeric states.
Concept Circular Dichroism
Search Criteria
  • Circular Dichroism
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.